AI assistant
Revolution Medicines, Inc. — Director's Dealing 2021
Sep 22, 2021
30695_dirs_2021-09-21_bf5c416a-ee5a-470d-8ecb-6a7526f6c0cb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Revolution Medicines, Inc. (RVMD)
CIK: 0001628171
Period of Report: 2021-09-17
Reporting Person: GOLDSMITH MARK A (Director, See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-17 | Common Stock | S | 1531 | $30.02 | Disposed | 46472 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 37032 | Indirect |
| Common Stock | 37032 | Indirect |
| Common Stock | 266506 | Indirect |
Footnotes
F1: Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F2: Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F3: Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
F4: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
F5: Includes 42,000 RSUs.